Skip to main content
Premium Trial:

Request an Annual Quote

Australia s Cryptome to Use Northeastern University s Proteomics Technology

NEW YORK, April 6 (GenomeWeb News) - Cryptome Pharmaceuticals, a Melbourne, Australia-based drug discovery firm, said today that it has signed an agreement with NortheasternUniversity to use proteomics technology developed at the university.

 

Cryptome said it will use technology developed by William Hancock at Northeastern, which identifies and isolates low-abundance human proteins.

 

Hancock is a member of Cryptome's scientific advisory board.

 

Cryptome said that the methodology will augment its own discovery platform, which uses high-throughput screening to identify peptides of natural proteins that have previously unrecognized potential as therapeutic drugs.

 

Cryptome will retain all commercial rights to new drug candidates developed as part of the collaboration.

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.